NADC3

There is 1 paper on NADC3 in aging research: none in people yet, 1 in cells.

Gene

1 paper studies it3 findings

HGNCNCBI GeneTaxon

See all 1 papers on NADC3

At a glance

The findings reach cells, none yet in people. 1 lab in 1 country.

None of its findings points the other way.

Cells: a single group. Worms or flies, mice and humans: nothing yet.
  • 1 lab in 1 country
  • Funders: National Key Research and Development Program of China and 1 more
  • Cells1

Effects

3

NAD/NADH ratio

downin human cells1

1 study
  1. NADC3 decreases NAD/NADH ratio in human cells (NaDC3 overexpression in WI38 cells).

    “The NAD(+)/NADH ratio in WI38/hNaDC3 cells was also decreased.”

    CellsNaDC3 overexpression in WI38 cells

    High-affinity Na(+)-dependent dicarboxylate cotransporter promotes cellular senescence by inhibiting SIRT1

    Mechanisms of ageing and development

More on NAD/NADH ratio

SIRT1

downin human cells1

1 study
  1. NADC3 decreases SIRT1 in human cells (NaDC3 overexpression in WI38 and MRC-5 cells).

    “Meanwhile, the level of SIRT1 activity was down-regulated.”

    CellsNaDC3 overexpression in WI38 and MRC-5 cells

    High-affinity Na(+)-dependent dicarboxylate cotransporter promotes cellular senescence by inhibiting SIRT1

    Mechanisms of ageing and development

More on SIRT1

Aging-related phenotypes

upin human cells1

1 study
  1. NADC3 increases aging-related phenotypes in human cells (overexpression in WI38 and MRC-5 cells).

    “After NaDC3 was overexpressed in two human embryo lung fibroblastic cell lines, WI38 and MRC-5, we found that the cells displayed aging-related phenotypes in advance.”

    Cellsoverexpression in WI38 and MRC-5 cells

    High-affinity Na(+)-dependent dicarboxylate cotransporter promotes cellular senescence by inhibiting SIRT1

    Mechanisms of ageing and development

Latest